Entries of Dunst, Jürgen on the publication server

Schäfer, Rebekka, Strnad, Vratislav, Polgár, Csaba, Uter, Wolfgang, Hildebrandt, Guido, Ott, Oliver J., Kauer-Dorner, Daniela, Knauerhase, Hellen, Major, Tibor, Lyczek, Jaroslaw, Guinot, Jose Luis, Dunst, Jürgen, Miguelez, Cristina Gutierrez, Slampa, Pavel, Allgäuer, Michael, Lössl, Kristina, Kovács, György, Fischedick, Arnt-René, Fietkau, Rainer, Resch, Alexandra, Kulik, Anna, Arribas, Leo, Niehoff, Peter, Guedea, Ferran, Schlamann, Annika, Gall, Christine, Polat, Bülent, Wendt, Thomas G., Hindemith, Marion, Pötter, Richard and Malzer, Martina (2018) Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial. The Lancet Oncology 19 (6), pp. 834-844. Fulltext not available.

Kuhnt, Thomas, Schreiber, Andreas, Pirnasch, Anett, Hautmann, Matthias G., Hass, Peter, Sieker, Frank P., Engenhart-Cabillic, Rita, Richter, Michael, Dellas, Kathrin and Dunst, Jürgen (2017) Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck. Strahlentherapie und Onkologie 193 (9), pp. 733-741. Fulltext not available.

Strnad, Vratislav, Ott, Oliver J., Hildebrandt, Guido, Kauer-Dorner, Daniela, Knauerhase, Hellen, Major, Tibor, Lyczek, Jaroslaw, Guinot, Jose Luis, Dunst, Jürgen, Miguelez, Cristina Gutierrez, Slampa, Pavel, Allgäuer, Michael, Lössl, Kristina, Polat, Bülent, Kovács, György, Fischedick, Arnt-René, Wendt, Thomas G., Fietkau, Rainer, Hindemith, Marion, Resch, Alexandra, Kulik, Anna, Arribas, Leo, Niehoff, Peter, Guedea, Fernando, Schlamann, Annika, Pötter, Richard, Gall, Christine, Malzer, Martina, Uter, Wolfgang and Polgár, Csaba (2016) 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. The Lancet 387 (10015), pp. 229-238. Fulltext not available.